|
1
|
Rodríguez Cruz PM, Cossins J, Beeson D and
Vincent A: The neuromuscular junction in health and disease:
Molecular mechanisms governing synaptic formation and homeostasis.
Front Mol Neurosci. 13(610964)2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Dresser L, Wlodarski R, Rezania K and
Soliven B: Myasthenia gravis: Epidemiology, pathophysiology and
clinical manifestations. J Clin Med. 10(2235)2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Huang K, Luo YB and Yang H: Autoimmune
channelopathies at neuromuscular junction. Front Neurol.
10(516)2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Hazard PB, Bertorini TE and Griffin JP:
Myasthenia gravis associated with small cell carcinoma of the lung.
J Tenn Med Assoc. 79:273–276. 1986.PubMed/NCBI
|
|
5
|
Fujita J, Yamadori I, Yamaji Y, Yamagishi
Y, Takigawa K and Takahara J: Myasthenia gravis associated with
small-cell carcinoma of the lung. Chest. 105:624–625.
1994.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Miyoshi R, Yamaji Y, Shima S, Fujita J,
Okada H and Takahara J: A case of small cell lung cancer that
developed during therapy for myasthenia gravis. Nihon Kyobu Shikkan
Gakkai Zasshi. 33:456–462. 1995.PubMed/NCBI(In Japanese).
|
|
7
|
Leavitt JA: Myasthenia gravis with a
paraneoplastic marker. J Neuroophthalmol. 20:102–105.
2000.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Sakamaki Y, Yoon HE and Oda N:
Non-small-cell lung cancer associated with non-thymomatous
myasthenia gravis. Jpn J Thorac Cardiovasc Surg. 54:207–211.
2006.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Takagi M and Akiba T: A case of surgically
treated primary lung cancer with myasthenia gravis. Nihon Kokyuki
Gakkai Zasshi. 45:198–201. 2007.PubMed/NCBI(In Japanese).
|
|
10
|
Kataoka K, Fujiwara T, Matsuura M and Seno
N: A case of simultaneously operated primary multiple lung cancers
with nonthymomatous myasthenia gravis. Jpn J Lung Cancer.
49:273–277. 2009.(In Japanese).
|
|
11
|
Peltier AC, Black BK, Raj SR, Donofrio P,
Robertson D and Biaggioni I: Coexistent autoimmune autonomic
ganglionopathy and myasthenia gravis associated with non-small-cell
lung cancer. Muscle Nerve. 41:416–419. 2010.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Shaygannejad V, Ghasemi M and Rajaee Z:
Myasthenia gravis as a presenting feature in a patient with lung
cancer: A case report. J Res Med Sci. 16:229–232. 2011.PubMed/NCBI
|
|
13
|
Ohira M, Jeong D and Oh SJ: Seropositive
myasthenia gravis associated with small-cell lung carcinoma. J Clin
Neurol. 7:43–46. 2011.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Takizawa M, Oda M, Matsumoto I, Waseda R,
Tanaka N and Watanabe G: Myasthenia gravis complicated with lung
cancer and middle mediastinal thymoma. Asian Cardiovasc Thorac Ann.
20:486–488. 2012.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Niimi K, Nagata E, Murata N, Sato M,
Tanaka J, Horio Y, Takiguchi H, Tomomatsu H, Tomomatsu K, Hayama N,
et al: Lung cancer associated with seronegative myasthenia gravis.
Intern Med. 54:1381–1384. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Yamasaki M, Funaishi K, Saito N, Yonekawa
T, Yamawaki T, Ihara D, Daido W, Ishiyama S, Deguchi N, Taniwaki M
and Hattori N: Acetylcholine receptor antibody-positive myasthenia
gravis associated with small-cell lung cancer: A case report.
Medicine (Baltimore). 97(e0541)2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Jia R, Chen J, Ge R, Zheng Q, Chen F and
Zhao Z: Coexistence of myasthenia gravis and Lambert-Eaton
myasthenic syndrome in a small cell lung cancer patient: A case
report. Medicine (Baltimore). 97(e10976)2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Stathopoulos P, Kumar A, Heiden JA,
Pascual-Goñi E, Nowak RJ and O'Connor KC: Mechanisms underlying B
cell immune dysregulation and autoantibody production in MuSK
myasthenia gravis. Ann NY Acad Sci. 1412:154–165. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Safa H, Johnson DH, Trinh VA, Rodgers TE,
Lin H, Suarez-Almazor ME, Fa'ak F, Saberian C, Yee C, Davies MA, et
al: Immune checkpoint inhibitor related myasthenia gravis: Single
center experience and systematic review of the literature. J
Immunother Cancer. 7(319)2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Makarious D, Horwood K and Coward JI:
Myasthenia gravis: An emerging toxicity of immune checkpoint
inhibitors. Eur J Cancer. 82:128–136. 2017.PubMed/NCBI View Article : Google Scholar
|
